NCGC00024596-07

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

38 Suppliers, 20 USDMF, 15 CEP/COS, 8 JDMF, 1 EU WC, 7 KDMF, 15 NDC API, 18 Listed Suppliers

DEVELOPMENTS

24 Drug(s) in Development

24 Drug(s) in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports, FDF Imports

DOSSIERs // Finished Dosage Forms

313 Dossiers, 112 FDA Orange Book, 137 Europe, 18 Canada, 5 Australia, 12 South Africa, 29 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET;ORAL - 10MG;100MG, TABLET;ORAL - 25MG;100MG, TABLET;ORAL - 25MG;250MG, TABLET;ORAL - 25MG, TABLET, EXTENDED RELEASE;ORAL - 25MG;100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 50MG;200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 12.5MG;200MG;50MG, TABLET;ORAL - 18.75MG;200MG;75MG, TABLET;ORAL - 25MG;200MG;100MG, TABLET;ORAL - 31.25MG;200MG;125MG, TABLET;ORAL - 37.5MG;200MG;150MG, TABLET;ORAL - 50MG;200MG;200MG

RELATED EXCIPIENT COMPANIES

Suppliers, 33 Kerry, 29 BASF, 29 Roquette, 20 SPI Pharma, 17 Microlex e.U, 13 Gangwal Healthcare, 13 Seppic, 12 Corel Pharma Chem, 12 Sigachi Industries, 12 Gangwal Chemicals, 11 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 11 Ideal Cures Pvt Ltd, 8 Actylis, 7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 7 Boai NKY Pharmaceuticals Ltd, 6 Lonza Capsugel, 6 DFE Pharma, 5 Kima Chemical, 5 Prachin Chemical, 5 Pharmatrans-Sanaq, 5 Ingredion Pharma Solutions, 5 Nanjing Well Pharmaceutical, 4 Vasa Pharmachem, 4 DKSH, 4 Rochem International Inc, 4 The Dow Chemical Company, 3 Jai Radhe Sales, 3 Ulanqab Kema New Material, 2 Shijiazhuang Huaxu Pharmaceutical, 2 Evonik, 2 Pfanstiehl, 2 Alcedo Pharmachem, 2 Nomisma Healthcare, 2 Seqens, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Aeon Procare, 1 ACG Worldwide, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Qualicaps, 1 NEWEDGE Overseas, 1 Chynops Pharma, 1 Nanjing Bold Chemical, 1 Minakem, 1 Finar, 1 Vertellus, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

88 Fillers, Diluents & Binders, 63 Coating Systems & Additives, 46 Disintegrants & Superdisintegrants, 43 Direct Compression, 39 Controlled & Modified Release, 31 Solubilizers, 30 Granulation, 29 Thickeners and Stabilizers, 26 Taste Masking, 22 Lubricants & Glidants, 21 Chewable & Orodispersible Aids, 21 Film Formers & Plasticizers, 19 Parenteral, 16 Co-Processed Excipients, 12 Topical, 9 API Stability Enhancers, 7 Emulsifying Agents, 6 Rheology Modifiers, 5 Empty Capsules, 4 Vegetarian Capsules, 3 Surfactant & Foaming Agents, 2 Coloring Agents, 1 Soft Gelatin

GLOBAL SALES INFORMATION

41 US Medicaid Prescriptions, 118 Finished Drug Prices

MARKET PLACE

10 APIs, 9 DOSSIERS // FDF

PATENTS

65 US Patents

65 US Patents

ANALYTICAL SOLUTION(s)

1 BioAnalytical Methods, 3 EDQM Standards, 2 USP Standards, 1 JP Standards, 7 Other Ref. Standards

DIGITAL CONTENT

4 Data Compilation & Company Tracker #PharmaFlow, 64 News

Annual Sales of NCGC00024596-07 reported using PharmaCompass' compilation of Annual Reports of Global Pharmaceutical Companies.

NCGC00024596-07

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

38 Suppliers

20 USDMF

15 CEP/COS

8 JDMF

1 EU WC

7 KDMF

15 NDC API

18 Listed Suppliers

DEVELOPMENTS

24 Drug(s) in Development

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Exports

FDF Imports

DOSSIERs // Finished Dosage Forms

313 Dossiers

112 FDA Orange Book

137 Europe

18 Canada

5 Australia

12 South Africa

29 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET;ORAL - 10MG;100MG

TABLET;ORAL - 25MG;100MG

TABLET;ORAL - 25MG;250MG

TABLET;ORAL - 25MG

TABLET, EXTENDED RELEASE;ORAL - 25MG;100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, EXTENDED RELEASE;ORAL - 50MG;200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 12.5MG;200MG;50MG

TABLET;ORAL - 18.75MG;200MG;75MG

TABLET;ORAL - 25MG;200MG;100MG

TABLET;ORAL - 31.25MG;200MG;125MG

TABLET;ORAL - 37.5MG;200MG;150MG

TABLET;ORAL - 50MG;200MG;200MG

RELATED EXCIPIENT COMPANIES

Suppliers

33 Kerry

29 BASF

29 Roquette

20 SPI Pharma

17 Microlex e.U

13 Gangwal Healthcare

13 Seppic

12 Corel Pharma Chem

12 Sigachi Industries

12 Gangwal Chemicals

11 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

11 Ideal Cures Pvt Ltd

8 Actylis

7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

7 Boai NKY Pharmaceuticals Ltd

6 Lonza Capsugel

6 DFE Pharma

5 Kima Chemical

5 Prachin Chemical

5 Pharmatrans-Sanaq

5 Ingredion Pharma Solutions

5 Nanjing Well Pharmaceutical

4 Vasa Pharmachem

4 DKSH

4 Rochem International Inc

4 The Dow Chemical Company

3 Jai Radhe Sales

3 Ulanqab Kema New Material

2 Shijiazhuang Huaxu Pharmaceutical

2 Evonik

2 Pfanstiehl

2 Alcedo Pharmachem

2 Nomisma Healthcare

2 Seqens

1 Qianhao Chemical (Hebei) Co., Ltd

1 Aeon Procare

TABLET, EXTENDED RELEASE;ORAL - 25MG;100MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET, EXTENDED RELEASE;ORAL - 50MG;200MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons